EFFECTS OF HIGH-DOSE KETOCONAZOLE ON PATIENTS WHO HAVE ANDROGEN-INDEPENDENT PROSTATIC-CANCER

被引：0
作者：
EICHENBERGER, T
TRACHTENBERG, J
机构：
[1] TORONTO GEN HOSP,DEPT SURG,DIV UROL,EN-14-209,200 ELIZABETH ST,TORONTO M5G 2C4,ONTARIO,CANADA
[2] UNIV TORONTO,TORONTO M5S 1A1,ONTARIO,CANADA
来源：
CANADIAN JOURNAL OF SURGERY | 1989年 / 32卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：349 / 352
页数：4
相关论文
共 50 条
[21]   A phase I/II study of high-dose tamoxifen in combination with vinblastine in patients with androgen-independent prostate cancer [J].
Hamilton, M ;
Dahut, W ;
Brawley, O ;
Davis, P ;
Wells-Jones, T ;
Kohler, D ;
Duray, P ;
Liewehr, DJ ;
Lakhani, N ;
Steinberg, SM ;
Figg, WD ;
Reed, E .
ACTA ONCOLOGICA, 2003, 42 (03) :195-201
[22]   COMBINED KETOCONAZOLE AND LHRH PRODUCING OBJECTIVE RESPONSES IN PATIENTS WITH PROSTATIC-CANCER WHO HAVE FAILED CONVENTIONAL TREATMENT [J].
KERLE, D ;
WARE, H ;
SMITH, CB ;
YEO, T ;
ALLEN, J ;
BLOOM, SR ;
WILLIAMS, G .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1984, 20 (6B) :1395-1395
[23]   ANDROGEN INVOLVEMENT IN THE DEVELOPMENT OF ANDROGEN INDEPENDENT PROSTATIC-CANCER CELLS [J].
KYPRIANOU, N ;
ISAACS, JT .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 :240-240
[24]   DERIVATION OF ANDROGEN-INDEPENDENT HUMAN LNCAP PROSTATIC-CANCER CELL SUBLINES - ROLE OF BONE STROMAL CELLS [J].
WU, HC ;
HSIEH, JT ;
GLEAVE, ME ;
BROWN, NM ;
PATHAK, S ;
CHUNG, LWK .
INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (03) :406-412
[25]   A phase II study of high-dose calcitriol combined with mitoxantrone and prednisone for androgen-independent prostate cancer [J].
Chan, Joseph S. ;
Beer, Tomasz M. ;
Quinn, David I. ;
Pinski, Jacek K. ;
Garzotto, Mark ;
Sokoloff, Mitchell ;
Dehaze, Daniel R. ;
Ryan, Christopher W. .
BJU INTERNATIONAL, 2008, 102 (11) :1601-1606
[26]   KETOCONAZOLE LOWERS SERUM ANDROGENS IN PATIENTS WITH PROSTATIC-CANCER [J].
TRACHTENBERG, J .
CLINICAL RESEARCH, 1983, 31 (03) :A696-A696
[27]   Response to ketoconazole after failure of docetaxel in patients with advanced androgen-independent prostate cancer (AIPC). [J].
Jean, G. W. ;
Shah, S. ;
Keisner, S. V. ;
GressettUssery, S. M. ;
Dowell, J. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[28]   INHIBITION OF GROWTH AND INCREASE OF ACID-PHOSPHATASE BY TESTOSTERONE ON ANDROGEN-INDEPENDENT MURINE PROSTATIC-CANCER CELLS TRANSFECTED WITH ANDROGEN RECEPTOR CDNA [J].
SUZUKI, H ;
NIHEI, N ;
SATO, N ;
ICHIKAWA, T ;
MIZOKAMI, A ;
SHIMAZAKI, J .
PROSTATE, 1994, 25 (06) :310-319
[29]   Oral low-dose dexamethasone for androgen-independent prostate cancer patients [J].
Komiya, Akira ;
Shimbo, Masaki ;
Suzuki, Hiroyoshi ;
Imamoto, Takashi ;
Kato, Tomonori ;
Fukasawa, Satoshi ;
Kamiya, Naoto ;
Naya, Yukio ;
Mori, Ikuo ;
Ichikawa, Tomohiko .
ONCOLOGY LETTERS, 2010, 1 (01) :73-79
[30]   High-dose calcitriol, docetaxel, and estramustine in androgen-independent prostate cancer (AIPC): A phase I/II study. [J].
Tiffany, NM ;
Ryan, CW ;
Garzotto, M ;
Wersinger, EM ;
Beer, TM .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :426S-426S
12345